Zenotech Laboratories Ltd Financials
Company Logo

Zenotech Laboratories Ltd Financial Statement

Zenotech Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue12.62
Operating Expense7.71
Net Profit1.23
Net Profit Margin9.75
Earning Per Share0.20
EBIDTA5.45
Effective Tax Rate50.71

Zenotech Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual43.05
Operating Expenses Annual28.87
Operating Profit Annual17.65
Interest AnnualTBA
Depreciation6.96
Net Profit Annual5.61
Tax Annual5.08

Zenotech Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning1.82
Cash Flow from Operations9.49
Cash Flow from Investing15.27
Cash Flow from FinancingTBA
Cash Flow at the End26.58

Zenotech Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)36.54
PBIT Margin (%)20.37
PBT Margin (%)20.37
Net PROFIT Margin (%)13.03
Return On Networth / Equity (%)1.66
Return On Networth /Employed (%)3.21
Return On Assets (%)5.86
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)0.45

Zenotech Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual60.87
Total Current Assets Annual35.99
Non Current Assets Annual75.04
Total Shareholders Funds Annual96.13
Total Assets Annual111.03

Zenotech Laboratories Ltd Earning Calls

No Data Availabe

FAQS on Zenotech Laboratories Ltd Financials

As of Jul 26, 2025, Zenotech Laboratories Ltd has a market capitalization of 316.87 Cr. Value Research classifies it as a Small-Cap company.

Yes, Zenotech Laboratories Ltd is with a debt-to-equity ratio of 0.00.

In FY 2024 , Zenotech Laboratories Ltd recorded a total revenue of approximately 38.98 Cr marking a significant milestone in the company's financial performance.

Zenotech Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.0% and 0.0% annually, respectively..

Zenotech Laboratories Ltd's current PE ratio is 56.48.

Zenotech Laboratories Ltd's ROCE averaged 12.9% from the FY ending March 2023 to 2025, with a median of 12.2%. It peaked at 17.6% in March 2023, reflecting strong capital efficiency over the period..

Zenotech Laboratories Ltd's latest EBIT is Rs. 10.69 Cr, surpassing the average EBIT of Rs. 12.15 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions